Psychedelics are a hot topic, and a drug called ibogaine is receiving attention after a recent shoutout from U.S. President Donald Trump. University of Calgary psychedelics researcher Leah Mayo explains what ibogaine is, and why limited high-quality research has her hesitant to recommend it.

For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.

Erectile dysfunction is commonly thought of as a sexual health issue, but experts say the condition can reveal a lot about men's health. Dr. Dean Elterman, a urologist at the University Health Network in Toronto, says ED can be connected to a host of other health problems including diabetes and heart disease.

For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.

Some private clinics in Canada are offering whole-body MRIs that can run thousands of dollars. They claim these scans can detect a range of issues, and can find cancers in the early stages. Dr. Iain Kirkpatrick, the head of radiology at St. Boniface Hospital in Winnipeg, explains what a whole-body MRI can - and can’t - tell you about your health.

Young female athletes are considerably more likely to tear their anterior cruciate ligaments, or ACLs, than young men. Dr. Marie-Lyne Nault is an orthopedic surgeon and researcher specializing in pediatric sports medicine in Montreal. She explains why the risk is higher, and how women and teens can significantly reduce the risk of a tear.

For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.

Meningococcal disease is a rare but potentially lethal bacterial infection. Two young people died in a recent outbreak in the U.K. Infectious diseases specialist Dr. Isaac Bogoch explains what you need to know about this disease and how to protect yourself.

For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.

Psilocybin, the active compound in magic mushrooms, shows promise for treating depression and other mental health conditions. Dr. Joshua Rosenblat, a psychiatrist and researcher at the Krembil Brain Institute at UHN, explains the latest research and its potential for future treatments—though it's still illegal in Canada.

Wellness influencers on social media are touting injectable peptides as a new wonder drug, claiming compounds like BPC-157 can improve muscle strength, boost recovery times and even increase longevity. But University of Alberta health misinformation expert Tim Caulfield says the evidence doesn’t support the hype, and warns people against injecting unregulated substances.

For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.

A recent survey found roughly three million Canadians are taking GLP-1 medications like Ozempic and Mounjaro. The drugs can reduce appetite and cravings, and could also affect the body’s fat and muscle stores. Registered dietitian and Obesity Canada's Jennifer Brown says people on GLP-1 drugs may need to be more intentional about what they eat — from protein and micronutrients to fibre and fluids.

For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.